Insights

European Leader Target European healthcare providers specializing in cardiology and vascular interventions, highlighting Biotronik's focus on electrotherapy for the heart and vascular interventions to position as a trusted supplier with regional expertise.

Innovative Products Leverage Biotronik Schweiz AG’s Dynetic-35 balloon-expandable cobalt chromium iliac stent system as a flagship offering to hospitals seeking next-generation stents, emphasizing performance, durability, and clinical relevance.

SME Growth Opportunity With a small revenue range and 501-1000 employees, pursue mid-market hospital networks and regional distributors where Biotronik can provide flexible partnerships, support services, and targeted training to accelerate adoption.

Digital & Tech Enablement Utilize the company’s tech stack (Microsoft 365, Vue.js, Element UI, three.js, Apache) to offer value-added digital integration services, such as cloud-based deployment support, data integration with hospital IT systems, and streamlined customer portals.

Competitive Positioning Differentiate from large incumbents by emphasizing European manufacturing, specialized focus on cardiac electrophysiology and vascular solutions, and proven next-generation stent technology to win RFPs and localized procurement cycles.

Teleflex / Vascular Intervention Biotronik AG Tech Stack

Teleflex / Vascular Intervention Biotronik AG uses 7 technology products and services including Microsoft 365, Vue.js, Element UI, and more. Explore Teleflex / Vascular Intervention Biotronik AG's tech stack below.

  • Microsoft 365
    Email
  • Vue.js
    Javascript Frameworks
  • Element UI
    Javascript Frameworks
  • Office 365
    Office Suites
  • three.js
    Programming Languages
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Teleflex / Vascular Intervention Biotronik AG's Email Address Formats

Teleflex / Vascular Intervention Biotronik AG uses at least 2 format(s):
Teleflex / Vascular Intervention Biotronik AG Email FormatsExamplePercentage
First.Last@biotronik.comJohn.Doe@biotronik.com
96%
FirstLast@biotronik.comJohnDoe@biotronik.com
2%
First.Middle@biotronik.comJohn.Michael@biotronik.com
1%
LastF@biotronik.comDoeJ@biotronik.com
1%
First.Last@biotronik.chJohn.Doe@biotronik.ch
100%

Frequently Asked Questions

What is Teleflex / Vascular Intervention Biotronik AG's official website and social media links?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's official website is biotronik.ch and has social profiles on LinkedIn.

What is Teleflex / Vascular Intervention Biotronik AG's NAICS code?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Teleflex / Vascular Intervention Biotronik AG have currently?

Minus sign iconPlus sign icon
As of July 2026, Teleflex / Vascular Intervention Biotronik AG has approximately 501 employees across 2 continents, including EuropeNorth America. Key team members include Head Of Customer Service & Sales Support: A. V.Managing Director: M. A.Director Strategy & Project Portfolio Management: N. L.. Explore Teleflex / Vascular Intervention Biotronik AG's employee directory with LeadIQ.

What industry does Teleflex / Vascular Intervention Biotronik AG belong to?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG operates in the Medical Equipment Manufacturing industry.

What technology does Teleflex / Vascular Intervention Biotronik AG use?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's tech stack includes Microsoft 365Vue.jsElement UIOffice 365three.jsApache HTTP ServerApache.

What is Teleflex / Vascular Intervention Biotronik AG's email format?

Minus sign iconPlus sign icon
Teleflex / Vascular Intervention Biotronik AG's email format typically follows the pattern of First.Last@biotronik.com. Find more Teleflex / Vascular Intervention Biotronik AG email formats with LeadIQ.
Teleflex / Vascular Intervention Biotronik AG logo

Teleflex / Vascular Intervention Biotronik AG

Medical Equipment ManufacturingRhineland-palatinate, Germany501-1000 Employees

Teleflex / Vascular Intervention Biotronik AG is a European medical technology company in the medical equipment manufacturing industry. The organization focuses on two business areas: cardiac electrotherapy and vascular intervention, developing devices to support clinicians in treating patients. The company is located at 4 Neuhofstrasse Baar, Rhineland-palatinate, Germany, and employs between 501 and 1000 people. Its website is https://biotronik.ch. In 2020, Biotronik Schweiz AG announced the availability of its next-generation balloon-expandable cobalt chromium iliac stent system, Dynetic-35, reflecting ongoing product development in vascular intervention. Revenue is reported in the range of $0–1 million.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $1M

    Teleflex / Vascular Intervention Biotronik AG's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Teleflex / Vascular Intervention Biotronik AG's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.